
The Nikkei 225 is modestly lower by 0.19% in choppy trading on Thursday, giving back some recent gains, as investors remain cautious amid mixed reports on Covid-19 vaccine efficacy against the fast-spreading Omicron variant, despite broadly positive cues from Wall Street. Key individual stocks show mixed performance, with market heavyweight SoftBank Group gaining over 1% while major exporters like Panasonic and Sony are down, reflecting broader market uncertainty.
The Japanese stock market is exhibiting cautious and divergent behavior, with the Nikkei 225 index declining modestly by 0.19% to 28,805.13 despite a positive lead from Wall Street. This risk-off sentiment is primarily fueled by investor uncertainty regarding the efficacy of existing vaccines against the Omicron Covid-19 variant, a concern that is also reflected in weaker European markets. The market's internal dynamics are highly mixed, indicating a selective rather than a broad-based downturn. Market heavyweight SoftBank Group posted a gain of over 1%, and tech firm Screen Holdings rose more than 1%, while major exporters and financials faced headwinds. Panasonic and Sony were down nearly 2% and 1% respectively, and the banking sector saw losses, with Mitsubishi UFJ Financial falling almost 1%. The negative sentiment is further highlighted by significant losses in specific names like Hitachi Zosen (-5%) and Mitsubishi Motors (-3%), while the U.S. dollar trading in the higher 113 yen-range presents an additional challenge for Japanese exporters.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment